Sophia Y Chen1, Miloslawa Stem1, Susan L Gearhart1, Bashar Safar1, Sandy H Fang1, Nilofer S Azad2, Adrian G Murphy2, Amol K Narang3, Christopher L Wolfgang1, Jonathan E Efron4,5. 1. Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. 2. Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. 3. Department of Radiation Oncology & Molecular Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. 4. Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. jefron1@jhmi.edu. 5. Mark M. Ravitch Professor of Surgery, The Johns Hopkins University School of Medicine, 733 North Broadway, Suite G-45, Baltimore, MD, 21205, USA. jefron1@jhmi.edu.
Abstract
BACKGROUND: Readmission has received attention as a potential healthcare quality metric. No studies have investigated the relationship between readmission and survival in patients undergoing rectal cancer surgery. The aims of this study were to identify factors associated with 30-day readmission after rectal cancer surgery and to determine the impact of readmission on overall survival (OS). METHODS: Patients who underwent surgical treatment for rectal/rectosigmoid adenocarcinoma stages I-IV were identified using the National Cancer Database (2004-2014). Multivariable logistic regression was used to identify factors for readmission. 2:1 nearest neighbor caliper matching without replacement was used to ensure similarity of patients being compared. Survival analyses were performed using Kaplan-Meier method along with log-rank test and Cox proportional hazards model. RESULTS: Of 110,167 patients, 7045 (6.39%) were readmitted. Factors associated with readmission included higher Charlson comorbidity score, non-private or no insurance, procedure type, hospitals in the Northeast, South, and Midwest regions, and prolonged length of stay. Within the matched cohort (13,756 non-readmitted and 6878 readmitted), readmitted patients had worse 5- and 10-year OS regardless of cancer stage (p < 0.001) and procedure type. Five- and 10-year OS were 58.98% and 41.01% for readmitted patients, 64.96% and 43.50% for non-readmitted patients. Readmitted patients had shorter OS by 13.14 months and increased risk of mortality (HR 1.20, 95% CI 1.15-1.25, p < 0.001). CONCLUSIONS: Thirty-day readmission after rectal cancer surgery is associated with decreased OS. Efforts to reduce readmissions should be considered to advance cancer care and enhance the potential for improved patient survival.
BACKGROUND: Readmission has received attention as a potential healthcare quality metric. No studies have investigated the relationship between readmission and survival in patients undergoing rectal cancer surgery. The aims of this study were to identify factors associated with 30-day readmission after rectal cancer surgery and to determine the impact of readmission on overall survival (OS). METHODS:Patients who underwent surgical treatment for rectal/rectosigmoid adenocarcinoma stages I-IV were identified using the National Cancer Database (2004-2014). Multivariable logistic regression was used to identify factors for readmission. 2:1 nearest neighbor caliper matching without replacement was used to ensure similarity of patients being compared. Survival analyses were performed using Kaplan-Meier method along with log-rank test and Cox proportional hazards model. RESULTS: Of 110,167 patients, 7045 (6.39%) were readmitted. Factors associated with readmission included higher Charlson comorbidity score, non-private or no insurance, procedure type, hospitals in the Northeast, South, and Midwest regions, and prolonged length of stay. Within the matched cohort (13,756 non-readmitted and 6878 readmitted), readmitted patients had worse 5- and 10-year OS regardless of cancer stage (p < 0.001) and procedure type. Five- and 10-year OS were 58.98% and 41.01% for readmitted patients, 64.96% and 43.50% for non-readmitted patients. Readmitted patients had shorter OS by 13.14 months and increased risk of mortality (HR 1.20, 95% CI 1.15-1.25, p < 0.001). CONCLUSIONS: Thirty-day readmission after rectal cancer surgery is associated with decreased OS. Efforts to reduce readmissions should be considered to advance cancer care and enhance the potential for improved patient survival.
Authors: Heather L Yeo; Jonathan S Abelson; Jialin Mao; Paul R A O'Mahoney; Jeffrey W Milsom; Art Sedrakyan Journal: Ann Surg Date: 2017-01 Impact factor: 12.969
Authors: N J Curtis; E Noble; E Salib; R Hipkiss; E Meachim; R Dalton; A Allison; J Ockrim; N K Francis Journal: Colorectal Dis Date: 2017-08 Impact factor: 3.788
Authors: Jamin K Addae; Faiz Gani; Sandy Y Fang; Elizabeth C Wick; Azah A Althumairi; Jonathan E Efron; Joseph K Canner; David M Euhus; Eric B Schneider Journal: J Surg Res Date: 2016-09-17 Impact factor: 2.192
Authors: Chun Chieh Lin; Suanna S Bruinooge; M Kelsey Kirkwood; Dawn L Hershman; Ahmedin Jemal; B Ashleigh Guadagnolo; James B Yu; Shane Hopkins; Michael Goldstein; Dean Bajorin; Sharon H Giordano; Michael Kosty; Anna Arnone; Amy Hanley; Stephanie Stevens; Christine Olsen Journal: Int J Radiat Oncol Biol Phys Date: 2015-12-17 Impact factor: 7.038
Authors: Ravi P Kiran; Conor P Delaney; Anthony J Senagore; Malcolm Steel; Thomas Garafalo; Victor W Fazio Journal: J Am Coll Surg Date: 2004-06 Impact factor: 6.113
Authors: Varun Puri; Aalok P Patel; Traves D Crabtree; Jennifer M Bell; Stephen R Broderick; Daniel Kreisel; A Sasha Krupnick; G Alexander Patterson; Bryan F Meyers Journal: J Thorac Cardiovasc Surg Date: 2015-08-28 Impact factor: 5.209
Authors: Kevin A Chen; Chinmaya U Joisa; Karyn B Stitzenberg; Jonathan Stem; Jose G Guillem; Shawn M Gomez; Muneera R Kapadia Journal: J Gastrointest Surg Date: 2022-09-07 Impact factor: 3.267